Eversept Partners’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Eversept Partners’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-52,460	Closed	-$479K	–	106
2022 Q1	$479K	Sell	52,460 -11,498	-18%	-$175K	0.04%	77
2021 Q4	$1.37M	Sell	63,958 -52,993	-45%	-$1.42M	0.09%	84
2021 Q3	$3.82M	Sell	116,951 -12,452	-10%	-$456K	0.26%	57
2021 Q2	$4.91M	Buy	129,403 +41,410	+47%	+$2.12M	0.33%	47
2021 Q1	$5.75M	Buy	+87,993	New	+$6.14M	0.43%	47

Other funds holding SRGA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

CLG

Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Eversept Partners's SRGA Position: Q2 2022 in Review

Eversept Partners sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2022, closing a stake of 52,460 shares — an estimated $479K sold.

Eversept Partners first reported a position in SRGA in Q1 2021 and held it in 5 quarters. The position peaked at $5.75M in Q1 2021. 40 funds tracked by Wall St. Rank hold SRGA as of Q2 2022.

Eversept Partners reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Eversept Partners sold 52,460 Surgalign Holdings, Inc. Common Stock shares in Q2 2022, an estimated $479K.
Eversept Partners first reported a position in Surgalign Holdings, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
Eversept Partners's Surgalign Holdings, Inc. Common Stock position peaked at $5.75M in Q1 2021.
40 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2022.

Based on Eversept Partners's 13F filing for Q2 2022, filed 15 Aug 2022.